27 December 2024 false No description of principal activity Taxfiler 2024.6 16153827business:PrivateLimitedCompanyLtd2024-12-272025-12-31 161538272024-12-26 161538272024-12-272025-12-31 16153827business:AuditExemptWithAccountantsReport2024-12-272025-12-31 16153827business:FilletedAccounts2024-12-272025-12-31 161538272025-12-31 16153827business:Director12024-12-272025-12-31 16153827business:RegisteredOffice2024-12-272025-12-31 16153827core:WithinOneYear2025-12-31 16153827core:ShareCapitalcore:PreviouslyStatedAmount2025-12-31 16153827core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2025-12-31 16153827core:PreviouslyStatedAmount2025-12-31 16153827business:SmallEntities2024-12-272025-12-31 16153827countries:EnglandWales2024-12-272025-12-31 16153827core:AfterOneYear2025-12-31 iso4217:GBP xbrli:pure
Company Registration No. 16153827 (England and Wales)
PHARMASEEN LTD Unaudited accounts for the period from 27 December 2024 to 31 December 2025
PHARMASEEN LTD Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
PHARMASEEN LTD Company Information for the period from 27 December 2024 to 31 December 2025
Director
Stephanie Eguenoghene Natufe
Company Number
16153827 (England and Wales)
Registered Office
2 Christchurch Avenue Rainham Essex RM13 8JB England
Accountants
PAUL VICTORIA & CO 2ND FLOOR 134 SOUTH STREET ROMFORD ESSEX RM1 1TE
- 3 -
PHARMASEEN LTD Statement of financial position as at 31 December 2025
2025 
Notes
£ 
Current assets
Debtors
4
1 
Cash at bank and in hand
10,521 
10,522 
Creditors: amounts falling due within one year
5
(5,138)
Net current assets
5,384 
Net assets
5,384 
Capital and reserves
Called up share capital
1 
Profit and loss account
5,383 
Shareholders' funds
5,384 
For the period ending 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 17 September 2026 and were signed on its behalf by
Stephanie Eguenoghene Natufe Director Company Registration No. 16153827
- 4 -
PHARMASEEN LTD Notes to the Accounts for the period from 27 December 2024 to 31 December 2025
1
Statutory information
PHARMASEEN LTD is a private company, limited by shares, registered in England and Wales, registration number 16153827. The registered office is 2 Christchurch Avenue, Rainham, Essex, RM13 8JB, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
4
Debtors
2025 
£ 
Amounts falling due after more than one year
Other debtors
1 
5
Creditors: amounts falling due within one year
2025 
£ 
Taxes and social security
1,263 
Loans from directors
3,425 
Accruals
450 
5,138 
6
Average number of employees
During the period the average number of employees was 0.
- 5 -